Abstract
Purpose
A novel siRNA carrier was formulated between chitosan (CS) and thiamine pyrophosphate (TPP). Their ability to deliver siRNA were evaluated in stable and constitutive EGFP-expressing HepG2 cells.
Methods
CS-TPP was prepared by dissolving CS in TPP solution at a CS:TPP molar ratio of 1.5:1. Complexes of CS-TPP/siRNA were formed at varying weight ratios and characterized using gel electrophoresis. Their morphologies and particle sizes were evaluated, and the transfection efficiency and cytotoxicity of CS-TPP/siRNA complexes were examined in stable and constitutive EGFP-expressing HepG2 cells.
Results
Gel electrophoresis results indicated that binding of CS-TPP and siRNA depended on the molecular weight (MW) and weight ratio of CS, and the particle sizes of CS-TPP/siRNA complexes were in nano-size. The CS-TPP-mediated siRNA silencing of the endogenous EGFP gene occurred maximally with 70–73% efficiency. The CS-TPP/siRNA complex with the lowest MW of CS (20 kDa) at a weight ratio of 80 showed the strongest inhibition of gene expression, which was higher than Lipofectamine 2000™. Over 90% the average cell viabilities of the complexes were observed by MTT assay.
Conclusions
This study suggests that CS-TPP is straightforward to prepare, safe and exhibits significantly improved siRNA delivery potential in vitro.
Similar content being viewed by others
References
P. A. Sharp. RNA interference. Genes Dev. 15:485–490 (2001) doi:10.1101/gad.880001.
Y. Dorsett, and T. Tuschl. siRNAs: applications in functional genomics and potential as therapeutics. Nat. Rev. Drug Discov. 3:318–329 (2004) doi:10.1038/nrd1345.
R. C. Ryther, A. S. Flynt, J. A. Phillips, and J. G. Patton. siRNA therapeutics big potential from small RNAs. Gene Ther. 1:25–11 (2005).
B. Urban-Klein, S. Werth, S. Abuharbeid, F. Czubayko, and A. Aigner. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 12:461–466 (2005) doi:10.1038/sj.gt.3302425.
F. Takeshita, Y. Minakuchi, S. Nagahara, K. Honma, H. Sasaki, K. Hirai, T. Teratani, N. Namatame, Y. Yamamoto, K. Hanai, T. Kato, A. Sano, and T. Ochiya. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc. Natl. Acad. Sci. U. S. A. 102:12177–12182 (2005) doi:10.1073/pnas.0501753102.
C. N. Landen Jr., A. Chavez-Reyes, C. Bucana, R. Schmandt, M. T. Deavers, L.opez-G. Berestein, and A.K. Sood. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res. 65:6910–6918 (2005) doi:10.1158/0008-5472.CAN-05-0530.
A. Hassan, Y. Tian, W. Zheng, H. Ji, K. Sandberg, and J. G. Verbalis. Small interfering RNA-mediated functional silencing of vasopressin V2 receptors in the mouse kidney. Physiol. Genomics. 21:382–388 (2005) doi:10.1152/physiolgenomics.00147.2004.
B. I. Florea, M. Thanou, H. E. Junginger, and G. Borchard. Enhancement of bronchial octreotide absorption by chitosan and N-trimethyl chitosan shows linear in vitro/in vivo correlation. J. Control. Release. 110:353–361 (2006) doi:10.1016/j.jconrel.2005.10.001.
M. Lee, J.W. Nah, Y. Kwon, J. J. Koh, K. S. Ko, and S. W. Kim. Water-soluble and low molecular weight chitosan-based plasmid DNA delivery. Pharm. Res. 18:427–431 (2001) doi:10.1023/A:1011037807261.
T. Ishii, Y. Okahata, and T. Sato. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim. Biophys. Acta. 1514:51–64 (2001) doi:10.1016/S0005-2736(01)00362-5.
W. Weecharangsan, P. Opanasopit, T. Ngawhirunpat, T. Rojanarata, and A. Apirakaramwong. Chitosan lactate as a nonviral gene delivery vector in COS-1 cells. AAPS PharmSciTech. 7:E1–E6 (2006) doi:10.1208/pt070366.
X. Zhao, S. B. Yu, F. L. Wu, Z. B. Mao, and C. L. Yu. Transfection of primary chondrocytes using chitosan-pEEGFP nanoparticles. J. Control. Release. 112:223–228 (2006) doi:10.1016/j.jconrel.2006.01.016.
F. C. MacLaughlin, R.J. Mumper, J. Wang, J.M. Tagliaferri, I. Gill, M. HinCHyiffe, and A.P. Rolland. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J. Control. Release. 56:259–272 (1998) doi:10.1016/S0168-3659(98)00097-2.
M. Huang, C. W. Fong, E. Khorc, and L. Y. Lim. Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation. J. Control. Release. 106:391–406 (2005) doi:10.1016/j.jconrel.2005.05.004.
T. Kiang, J. Wen, H. W. Lim, and K. W. Leong. The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials. 25:5293–5301 (2004) doi:10.1016/j.biomaterials.2003.12.036.
M. Lavertu, S. Méthot, N. Tran-Khanh, and M.D. Buschmann. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials. 27:4815–4824 (2006) doi:10.1016/j.biomaterials.2006.04.029.
W. B. Tan, S. Jiang, and Y. Zhang. Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference. Biomaterials. 28:1565–1571 (2007) doi:10.1016/j.biomaterials.2006.11.018.
X. Liu, K. A. Howard, M. Dong, M. O. Andersen, U. L. Rahbek, M. G. Johnsen, O. C. Hansen, F. Besenbacher, and J. Kjems. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials. 28:1280–1288 (2007) doi:10.1016/j.biomaterials.2006.11.004.
J. Y. Pille, H. Li, E. Blot, J. R. Bertrand, L. L. Pritchard, P. Opolon, A. Maksimenko, H. Lu, J. P. Vannier, J. Soria, C. Malvy, and C. Soria. Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer. Hum. Gene Ther. 17:1019–1026 (2006) doi:10.1089/hum.2006.17.1019.
H. Katas, and H. O. Alpar. Development and characterisation of chitosan nanoparticles for siRNA delivery. J. Control. Release. 115:216–225 (2006).
K. A. Howard, U. L. Rahbek, X. Liu, C. K. Damgaard, S. Z. Glud, M. O. Andersen, M. B. Hovgaard, A. Schmitz, J. R. Nyengaard, F. Besenbacher, and J. Kjems. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol. Ther. 14:476–484 (2006) doi:10.1016/j.ymthe.2006.04.010.
W. Weecharangsan, P. Opanasopit, T. Ngawhirunpat, A. Apirakaramwong, T. Rojanarata, U. Ruktanonchai, and R. J. Lee. Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells. Int. J. Pharm. 348:161–168 (2008) doi:10.1016/j.ijpharm.2007.07.011.
P. C. Engel. Enzyme cofactors. In P. C. Engel (ed.), Enzymology LabFax, Academic, California, 1996, pp. 244–245.
M. D. Smith, J. C. Barbenel, J. M. Courtney, and M. H. Grant. Novel quantitative methods for the determination of biomaterial cytotoxicity. Int. J. Artif. Organs. 15:191–184 (1992).
A. C. Grayson, A. M. Doody, and D. Putnam. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharm. Res. 23:1868–1876 (2006) doi:10.1007/s11095-006-9009-2.
M. O. Andersen, K. A. Howard, S. R. Paludan, F. Besenbacher, and J. Kjems. Delivery of siRNA from lyophilized polymeric surfaces. Biomaterials. 29:506–512 (2008) doi:10.1016/j.biomaterials.2007.10.003.
K. Romóren, S. Pedersen, G. Smistad, O. Evensen, and B.J. Thu. The influence of formulation variables on in vitro transfection efficiency and physicochemical properties of chitosan-based polyplexes. Int. J. Pharm. 261:115–127 (2003) doi:10.1016/S0378-5173(03)00301-6.
T. Sato, T. Ishii, and Y. Okahata. In vitro gene delivery mediated by chitosan: effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials. 22:2075–2080 (2001) doi:10.1016/S0142-9612(00)00385-9.
Acknowledgements
The authors are grateful for financial support by Genetic Engineering and Biotechnology (BIOTEC), Thailand (grant number: BT-B-01-MG-16–4812), the Commission of Higher Education (Thailand), the Thailand Research Funds and National Research Council of Thailand.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rojanarata, T., Opanasopit, P., Techaarpornkul, S. et al. Chitosan-Thiamine Pyrophosphate as a Novel Carrier for siRNA Delivery. Pharm Res 25, 2807–2814 (2008). https://doi.org/10.1007/s11095-008-9648-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-008-9648-6